Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin- 2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent
Cheng Hua Jin, Maddeboina Krishnaiah, Domalapally Sreenu, Vura B. Subrahmanyam, Kota S. Rao, Hwa Jeong Lee, So Jung Park, Hyun Ju Park, Kiho Lee, Yhun Yhong Sheen, Dae Kee Kim
Research output: Contribution to journal › Article › peer-review
92Scopus
citations
Fingerprint
Dive into the research topics of 'Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin- 2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent'. Together they form a unique fingerprint.